Health
Pfizer’s COVID-19 shot less effective against South African variant: study – Global News
Some previous studies have indicated that the Pfizer shot was less potent against the B.1.351 variant than against other coronavirus variants, but still offered…
The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed.
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease. It matched age…
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Business8 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News20 hours agoAll this country music is giving me the honky-tonk blues